ProKidney Corp. - Class A Ordinary Shares - balanço patrimonial (NASDAQ:PROK) | MetaTrader

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Total de ativos 251.2 M518 M420.55 M441.07 M335.57 M Total de passivos 9.58 M13.06 M29.22 M39.44 M34.78 M Capital total -8.39 M-1.1 B-1.1 B-994.95 M-1.01 B Total de passivos e patrimônio líquido 251.2 M518 M420.55 M441.07 M335.57 M Dívida total ————— Dívida líquida —————

Notícias

ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue Estimates

Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Beats Revenue Estimates

ProKidney nomeia Greg Madison como diretor comercial

BofA mantém recomendação de desempenho inferior para ProKidney com preço-alvo de US$ 1

Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates

Aquestive Therapeutics (AQST) Reports Q4 Loss, Misses Revenue Estimates

ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK)

ProKidney Corp. (PROK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ProKidney Corp. (PROK) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:PROK) 2026-01-14

H.C. Wainwright inicia cobertura da ProKidney com recomendação de compra e preço-alvo de US$ 12

H.C. Wainwright initiates ProKidney stock with Buy rating, $12 target